berberine has been researched along with Diabetes Mellitus Type 1.5 in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Latent autoimmune diabetes in adults (LADA) is a heterogeneous form of diabetes, characterized by autoimmune destruction of pancreatic β-cells as well as insulin resistance and is triggered by environmental factors in the context of genetic susceptibility." | 7.11 | Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial. ( Mei, Z; Wu, X; Xiao, Y; Yan, J; Yang, W; Zhang, R; Zhou, Z, 2022) |
"Latent autoimmune diabetes in adults (LADA) is a heterogeneous form of diabetes, characterized by autoimmune destruction of pancreatic β-cells as well as insulin resistance and is triggered by environmental factors in the context of genetic susceptibility." | 3.11 | Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial. ( Mei, Z; Wu, X; Xiao, Y; Yan, J; Yang, W; Zhang, R; Zhou, Z, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, R | 1 |
Xiao, Y | 1 |
Yan, J | 1 |
Yang, W | 1 |
Wu, X | 1 |
Mei, Z | 1 |
Zhou, Z | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: A Randomized Controlled Trial[NCT04698330] | Phase 4 | 240 participants (Anticipated) | Interventional | 2022-05-31 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for berberine and Diabetes Mellitus Type 1.5
Article | Year |
---|---|
Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial.
Topics: Adult; Berberine; Diabetes Mellitus, Type 1; Glucose Intolerance; Humans; Insulin; Inulin; Latent Au | 2022 |